199 related articles for article (PubMed ID: 2881819)
1. Lack of adjuvant effect of the pertussis component on IPV DTP-polio vaccine in children.
Cadoz M; Montagnon B; Yvonnet B; Xueref C; Vincent-Falquet JC; Bandet R; Gibelin N
Dev Biol Stand; 1986; 65():153-8. PubMed ID: 2881819
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous administration of diphtheria/tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme.
Coursaget P; Yvonnet B; Relyveld EH; Barres JL; Diop-Mar I; Chiron JP
Dev Biol Stand; 1986; 65():169-75. PubMed ID: 2881821
[TBL] [Abstract][Full Text] [Related]
3. Use of a combined DTP-polio vaccine in a reduced schedule.
Swartz TA; Roumiantzeff M; Peyron L; Stopler T; Drucker J; Epstein I; Leitner L; Goldblum N
Dev Biol Stand; 1986; 65():159-66. PubMed ID: 2881820
[TBL] [Abstract][Full Text] [Related]
4. [The immunological basis of the administration of DTP-polio vaccine].
Cohen H
Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new combined inactivated DPT-polio vaccine.
Drucker J; Soula G; Diallo O; Fabre P
Dev Biol Stand; 1986; 65():145-51. PubMed ID: 3030861
[TBL] [Abstract][Full Text] [Related]
6. Vaccines and immunization schedules.
Nagel J
Trop Geogr Med; 1985 Sep; 37(3):S42-9. PubMed ID: 2866613
[TBL] [Abstract][Full Text] [Related]
7. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
8. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis].
Vodicková M; Svandová E
Cesk Pediatr; 1986 Jun; 41(6):321-3. PubMed ID: 2872973
[No Abstract] [Full Text] [Related]
9. Pertussis immunization of infants using a new combined DTP-polio vaccine.
Drucker J; Schatzmayr H; Grenier B; Ajjan N; Peyron L; Roumiantzeff M
Dev Biol Stand; 1985; 61():309-13. PubMed ID: 2872119
[TBL] [Abstract][Full Text] [Related]
10. Antibody level of New Zealand children immunized with the triple vaccine DTP (diphtheria-tetanus-pertussis).
Lau RC
Epidemiol Infect; 1988 Oct; 101(2):405-10. PubMed ID: 2903065
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine.
Gyhrs A; Lyngholm E; Larsen SO; Aggerbeck H; Heron I
Scand J Infect Dis; 1999; 31(6):579-85. PubMed ID: 10680989
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
Halperin SA; King J; Law B; Mills E; Willems P
Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
[TBL] [Abstract][Full Text] [Related]
13. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.
Lang J; Duong GH; Nguyen VG; Le TT; Nguyen CV; Kesmedjian V; Plotkin SA
Lancet; 1997 Jun; 349(9066):1663-5. PubMed ID: 9186385
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR;
Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088
[TBL] [Abstract][Full Text] [Related]
16. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
[TBL] [Abstract][Full Text] [Related]
17. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine.
Meriste S; Lutsar I; Tamm E; Willems P
Scand J Infect Dis; 2006; 38(5):350-6. PubMed ID: 16709537
[TBL] [Abstract][Full Text] [Related]
19. [Comparative immunologic effectiveness of variants of the DTP vaccine].
Baeva EA; Selezneva TS; Rezepov FF; Chebotareva SV; El'nitskaia EA
Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):50-2. PubMed ID: 2879402
[TBL] [Abstract][Full Text] [Related]
20. [The immunogenicity of vaccines against diphtheria, tetanus, pertussis and polio administered orally on the vaccinal calendar at the age of 2, 4 and 6 months and their coadministration with a hepatitis B vaccine at 0, 2 and 6 months].
Arístegui Fernández J; Muñiz Saitua J; Pérez Legorburu A; Imaz Pérez M; Arrate Zugazabeitia JP; Suárez Fernández MD; Goiri Zabala MD
An Esp Pediatr; 1996 Jan; 44(1):25-8. PubMed ID: 8849056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
